Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
J Oncol Pharm Pract. 2019 Dec;25(8):2062-2063. doi: 10.1177/1078155219858176. Epub 2019 Jun 21.
J Oncol Pharm Pract. 2019.
PMID: 31226917
No abstract available.
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.
Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H.
Urun Y, et al. Among authors: sendur mn.
J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. Epub 2018 Nov 6.
J Oncol Pharm Pract. 2019.
PMID: 30400750
Item in Clipboard
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y.
Arzu Yaşar H, et al. Among authors: sendur mn.
J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. Epub 2019 Mar 29.
J Oncol Pharm Pract. 2020.
PMID: 30924738
Item in Clipboard
Cite
Cite